Evaluation of the Treatment Environment Derived from the Expected Number of Patients Receiving Nuclear Medicine Drugs for Therapy Using 177Lu, 223Ra, and 131I and the Ability of Hospitals to Use These Nuclides and the Possibility of Introducing the Nuclide 225Ac
Released on J-STAGE: December 11, 2024 |
Volume 74
Issue 1
Pages 1-11
Makoto Hosono, Seigo Kinuya, Tatsuya Higashi, Hiroshi Onishi
Views: 143